Introduction The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different setting. Methods Research was conducted using PubMed, Scopus and Isi databases. Score quality and data extraction were performed for all the included studies. Results 23 articles met the criteria (15 cost-effectiveness analysis, CEA; 8 cost benefit analysis, CBA). The median score resulted in 91.8%: n.11 studies were considered of high quality, n.12 low quality. The mean score quality was 85.4%. Among the CEA, nine studies demonstrate the costeffectiveness of infant varicella vaccination compared to no vaccination. All the CBA substantially reported that varicella vaccine can reduce the number of cases, complications and hospitalizations. Discussion The studies are favorable to the introduction of universal varicella vaccination being cost saving and having a positive impact on morbidity. The quality score of the studies varied: recent analyses were not of higher quality. Key message The studies are favorable to the introduction of universal varicella vaccination.
Varicella vaccination: results of a systematic review of economic evaluations<subtitle>Brigid Unim</subtitle> / Saulle, Rosella; Unim, BRIGID ANDOUNIMYE; Boccalini, S; Bonanni, P; LA TORRE, Giuseppe. - In: EUROPEAN JOURNAL OF PUBLIC HEALTH. - ISSN 1101-1262. - ELETTRONICO. - 23 (suppl_1):(2013), pp. 249-250. (Intervento presentato al convegno 6th EUROPEAN PUBLIC HEALTH CONFERENCE 2013. Health in Europe: are we there yet? Learning from the past, building the future tenutosi a Brussels, Belgium nel 13 – 16 November 2013) [10.1093/eurpub/ckt124.031].
Varicella vaccination: results of a systematic review of economic evaluationsBrigid Unim
SAULLE, ROSELLA;UNIM, BRIGID ANDOUNIMYE;LA TORRE, Giuseppe
2013
Abstract
Introduction The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different setting. Methods Research was conducted using PubMed, Scopus and Isi databases. Score quality and data extraction were performed for all the included studies. Results 23 articles met the criteria (15 cost-effectiveness analysis, CEA; 8 cost benefit analysis, CBA). The median score resulted in 91.8%: n.11 studies were considered of high quality, n.12 low quality. The mean score quality was 85.4%. Among the CEA, nine studies demonstrate the costeffectiveness of infant varicella vaccination compared to no vaccination. All the CBA substantially reported that varicella vaccine can reduce the number of cases, complications and hospitalizations. Discussion The studies are favorable to the introduction of universal varicella vaccination being cost saving and having a positive impact on morbidity. The quality score of the studies varied: recent analyses were not of higher quality. Key message The studies are favorable to the introduction of universal varicella vaccination.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
